Agios Pharmaceuticals and the University of Pennsylvania Announce New Collaboration  
9/4/2012 9:58:02 AM

CAMBRIDGE, Mass. & PHILADELPHIA--(BUSINESS WIRE)--Agios Pharmaceuticals, Inc. (“Agios”) and The University of Pennsylvania (“Penn”) today announced that, in connection with the resolution of litigation announced earlier today, Agios and Penn have entered into a licensing agreement involving new intellectual property focused on the development of diagnostic products to detect the metabolism of certain cancers. The collaboration could result in significant benefits to cancer patients, as well as financial benefits to Agios, Penn and the Abramson Family Cancer Research Institute.